Blood Collection From Heart Failure Patients to Evaluate for Galectin-3 Measurement Differences Using Various Collection Tubes

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01980862

Enrollment

Registered

2013-11-11

Start date

2013-08-31

Completion date

2013-11-30

Last updated

2014-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To Measure Galectin-3 in Heart Failure Patients on Commercial Platforms

Brief summary

Single-site blood collection investigation.

Detailed description

45 Heart Failure patients will be recruited. Patients will provide a one-time blood sample specimen collection. Theses samples will be de-identified and provided for measurement of Galectin-3 on commercial platforms.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Heart Failure patients New York Heart Association class able to provide (4) collection tube types Subjects \> 18 years old All subjects must provide informed consent and associated documentation

Exclusion criteria

* Subjects that cannot tolerate blood withdrawal of 4 specimens collection tube tubes (approximately 40 mLs)

Design outcomes

Primary

Measure	Time frame
Obtain 45 matched donor serum and plasma samples sets collected from Heart Failure patients for galectin-3 measurements	6 months

Countries

United States

Outcome results